🔎 Trials Near Me

Dachaigh › Siostam Immune agus Galaran › California

Sgrùdaidhean clionaigeach Siostam Immune agus Galaran ann an California

Tha 18 sgrùdaidhean airson Siostam Immune agus Galaran a’ lorg phàirtichean aig làraichean ann an California.

Bailtean ann an California

Teacsa sgrùdaidh oifigeil (Beurla)

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

  • PCR Oncology, Arroyo Grande
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank
  • Washington Health, Fremont
  • agus 3 a bharrachd
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT04242095

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

  • City of Hope, Duarte
  • University of California, Irvine Medical Center - Hematology/Oncology, Orange
  • Stanford University School of Medicine, Stanford
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07192471

A Study of JADE101 in Participants With Immunoglobulin A Nephropathy

  • Jade Clinical Site, Chula Vista
A’ fastadhÌre 2
Aoisean 18 gu 60 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07541287

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
  • University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT06722235

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

  • City of Hope Comprehensive Cancer Center, Duarte
  • UCLA Medical Center, Los Angeles
  • Stanford Cancer Institute, Stanford
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT04996875

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
  • University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06948318

A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema

  • Northridge Clinical Trials, Northridge
A’ fastadhÌre 3
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT07765888

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

  • City of Hope, Duarte
  • Stanford University, Palo Alto
  • UCSF, San Francisco
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT07075185

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • University of California-Irvine Medical Center, Irvine
  • Cedars-Sinai Medical Center, Los Angeles
  • University of California, Los Angeles (UCLA) Medical Center, Los Angeles
  • agus 1 a bharrachd
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT05826535

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

  • Inmagene Site 1, Lancaster
  • Inmagene Site 23, Los Angeles
A’ fastadhÌre 2
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 12 Lùna 2026 · NCT07037901

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

  • UCLA Department of Medicine, Los Angeles
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT07216443

Atacicept in Multiple Glomerular Diseases

  • Vera Therapeutics, Brisbane
A’ fastadhÌre 2
Aoisean 2 agus nas sine · Gach gnè · Air ùrachadh 26 Ògmh 2026 · NCT06983028

A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition

  • University of California, San Francisco, San Francisco
A’ fastadhÌre 2
Gach aois · Gach gnè · Air ùrachadh 2 Ògmh 2026 · NCT05787574

A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)

  • Stanford University, Dept. of Dermatology, Redwood City
  • UC Davis, Dept. of Dermatology, Sacramento
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Cèit 2026 · NCT04422912

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

  • City of Hope, Duarte
  • Providence St. John's Health Center, Santa Monica
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Gibl 2026 · NCT03328078

Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers

  • USC / Norris Comprehensive Cancer Center, Los Angeles
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 19 agus nas sine · Gach gnè · Air ùrachadh 2 Gibl 2026 · NCT03207854

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

  • City of Hope National Medical Center, Duarte
  • Ronald Regan UCLA Medical Center, Los Angeles
  • University of California Irvine Health, Orange
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Dùbh 2025 · NCT06619561

Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

  • Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites, Culver City
A’ fastadhÌre 1/2Fàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Gibl 2022 · NCT04684602

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.